ROYAL BANK OF CANADA - BIOXCEL THERAPEUTICS INC ownership

BIOXCEL THERAPEUTICS INC's ticker is BTAI and the CUSIP is 09075P105. A total of 98 filers reported holding BIOXCEL THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.67 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of BIOXCEL THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,000
-46.2%
3,057
+60.3%
0.00%
Q2 2023$13,000
-55.2%
1,907
+18.6%
0.00%
Q1 2023$29,000
-49.1%
1,608
-40.5%
0.00%
Q4 2022$57,000
+533.3%
2,702
+259.3%
0.00%
Q3 2022$9,0000.0%752
+10.1%
0.00%
Q2 2022$9,000
-59.1%
683
-36.8%
0.00%
Q1 2022$22,000
-71.1%
1,081
-71.2%
0.00%
Q4 2021$76,000
-62.4%
3,758
-43.4%
0.00%
Q3 2021$202,000
+16.1%
6,644
+10.9%
0.00%
Q2 2021$174,000
-45.6%
5,991
-19.1%
0.00%
Q1 2021$320,000
+20.8%
7,406
+29.2%
0.00%
Q4 2020$265,000
+113.7%
5,734
+100.3%
0.00%
Q3 2020$124,000
+85.1%
2,862
+126.8%
0.00%
Q2 2020$67,000
+6600.0%
1,262
+2978.0%
0.00%
Q1 2020$1,000
-83.3%
41
-90.0%
0.00%
Q4 2019$6,000412
+20500.0%
0.00%
Q3 2019$0
-100.0%
2
-97.8%
0.00%
Q2 2019$1,00091
+600.0%
0.00%
Q3 2018$0
-100.0%
13
-99.5%
0.00%
Q1 2018$25,0002,4000.00%
Other shareholders
BIOXCEL THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 60,000$151,8000.16%
XTX Topco Ltd 33,605$85,0210.02%
Beacon Pointe Advisors, LLC 301,735$763,3900.01%
AllSquare Wealth Management LLC 4,527$11,4530.01%
Virtus ETF Advisers LLC 4,646$11,7540.01%
Y-Intercept (Hong Kong) Ltd 27,553$69,7090.01%
SeaCrest Wealth Management, LLC 16,550$41,8720.01%
Hennion & Walsh Asset Management, Inc. 33,940$85,8680.01%
Cutler Group LLC / CA 4,000$500.01%
Capital Investment Advisory Services, LLC 17,991$45,5170.00%
View complete list of BIOXCEL THERAPEUTICS INC shareholders